Cabbra

Cabbra

TBA
888 Views
Cabbra project goal is to set up a worldwide financial system with global partnerships that will be available for everyone and anytime 24/7. People using Cabbra will be able to buy whatever they'll like whether it will be first-use products, ordering food, paying a rent or proccessing company transactions etc. The project offers also others services, it will also establish its NFT marketplace, own staking program and invest in future technologies to improve its usage.
1.8
TOTAL SCORE
2.7
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Dates: TBA
Token info
Ticker: Cabbra
Platform: Binance Chain
Financial
Pre-sale Price : 0.50 USD
Soft cap: 250 000 000 USD
Social media
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Retreeb
Founded in 2019 Retreeb is a sustainable fintech. We develop a decentralized, simple and sustainable mobile payment method. It is a free payment service for consumers and relies on a multi-local stablecoin network and Fantom's infrastructure. It allows its users to act in accordance with the universal values of ethics, sharing and solidarity.
Upcoming
Fan360
The first sports community for fans, that covers the complete fan experience. Follow your favourite sports star, club or brand and get rewarded for engaging.
Upcoming
GoRecruit
GoRecruit is an AI recruitment system based on blockchain technology, which offers a new way of evaluating job applicants. The AI system, being a convenient online service, enables making HR decisions based on the analysis of data from social networks and publicly available sources. To select applicants for an interview, one does not need to spend several hours for processing and analyzing the data: one will acquire the detailed information with recommendations immediately after the authorization of a candidate in the GoRecruit system. This approach will make access to vacancies more open, eliminate human error in hiring, as well as reduce the cost of HR service by optimizing routine work.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.
Active
KardiaChain
KardiaChain is the blockchain of blockchains. A scalable and interoperable blockchain platform for decentralized applications. Our Vision: We believe Blockchain can create equal opportunities for people, a world where people have access to opportunity to invest, to start a business, to work and to be socially mobile. Our technology empowers mass adoption, expand use-cases and lay foundation of the blockchain ecosystem. We are building a blockchain platform for decentralised applications helping to create a blockchain ecosystem that allows for scaling and connecting disparate blockchains. Our Core Technology is: - Dual Node - Elastic Sharding With Incentive Mechanism (ESWIM) - Kardia Smart Contract Markup Language (KSML) Our Use cases are: - Supply Chain Management - Fully Decentralised Cross-chain Exchange - Smart City
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.